FAQ/Help |
Calendar |
Search |
Today's Posts |
07-09-2007, 02:00 PM | #1 | ||
|
|||
Junior Member
|
I think this is great news for all patients mainly for those who participated in phase I and phase II of the spheramine study.
This is a clear marketing and pre-commercialization job so one could guess that phase II results are good and launch is not so far away. Based on good phase II results maybe BayerSchering will file for a conditional approval. This will accelerate the process and do not forget Spheramine has fast track status. I press my thumbs for all patients here in this board who rely on this new approach. Good luck frank_ger |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Spheramine | Parkinson's Disease | |||
Spheramine ... | Parkinson's Disease | |||
spheramine interest | New Member Introductions | |||
Pagliarini starts as governor's deputy chief of staff | ALS | |||
Bayer Accused of Releasing AIDS and HIV tainted drugs in foriegn countries | General Health Conditions & Rare Disorders |